- Home
- NAAS vs HBIO Comparison
NAAS vs HBIO Comparison
Compare NAAS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAAS | HBIO |
|---|---|---|
| Founded | 2019 | 1901 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1M | 33.8M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NAAS | HBIO |
|---|---|---|
| Price | $3.45 | $0.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 32.6K | ★ 644.0K |
| Earning Date | 03-31-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,817,052.00 | ★ $87,371,000.00 |
| Revenue This Year | $378.49 | N/A |
| Revenue Next Year | N/A | $7.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.96 | $0.28 |
| 52 Week High | $40.32 | $2.28 |
Technical Indicators
Market Signals| Indicator | NAAS | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 50.58 |
| Support Level | $3.31 | $0.71 |
| Resistance Level | $3.65 | $0.80 |
| Average True Range (ATR) | 0.20 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 20.10 | 17.27 |
Price Performance
Historical ComparisonAbout NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.